Related Experiment Videos
Solar keratoses: analysis in a dermatological practice in Australia
Robert H Rosen1, Howard Studniberg
1Southern Suburbs Dermatology, Sydney, New South Wales, Australia. skindoc@bigpond.net.au
The Australasian Journal of Dermatology
|February 13, 2003
Summary
Patients with solar keratoses (SK) had significantly more lesions than the general population. Many SK patients also had non-melanoma skin cancers, including squamous cell carcinoma (SCC) and basal cell carcinoma (BCC).
Area of Science:
- Dermatology
- Oncology
- Epidemiology
Background:
- Solar keratoses (SK) are common pre-malignant skin lesions.
- Understanding the prevalence and associated skin cancers in SK patients is crucial for early detection and management.
Purpose of the Study:
- To quantify the burden of solar keratoses in a clinical cohort.
- To determine the incidence of non-melanoma skin cancer (NMSC) in patients with SK.
- To analyze the distribution and types of skin cancers associated with SK.
Main Methods:
- Retrospective analysis of 200 consecutive patients diagnosed with SK in a private dermatology practice.
- Data collection included lesion counts, presence and type of NMSC, and lesion site.
- Comparison of SK lesion counts with general population data.
Main Results:
- Patients presented with an average of 61.9 SK lesions, significantly higher than the general population average of 8.
- 41% of patients had co-existing NMSC, with 17% having squamous cell carcinoma (SCC).
- The ratio of basal cell carcinoma (BCC) to SCC was 1.7:1. SK lesions were most common on upper limbs, but densest on the face. SCCs were frequent on limbs, while BCCs were common on the head and neck.
Conclusions:
- Patients with solar keratoses represent a high-risk group for developing non-melanoma skin cancers.
- The high prevalence of SK and associated NMSC underscores the need for vigilant monitoring and treatment in dermatology practices.
- Topical treatments and preventative measures are essential for managing SK and reducing the risk of malignant transformation.